Biomaterial is a nonviable material used in medical devices or during interaction with biological systems. It is an essential material used for medical applications to substitute a part or a function of body in reliable, safe and physiologically acceptable method. It poses properties such as biocompatibility, high corrosion resistance, adequate strength, and bio-functionality. Some of the commonly used biomaterials are cellulose, silicone rubber, collagen, titanium, stainless steel, polyurethanes, poly (methyl methacrylate) and hydrogels.
The global biomaterial market is growing at a significant rate due to growing geriatric population, increasing prevalence of cardiovascular diseases, growing implantable device market and increasing number of hip and knee replacement. The technological advancements, increasing research and development activities and increasing healthcare expenditure are also driving the global biomaterial market. The increasing number of free trade agreements and growing healthcare market in emerging economies offer ample growth opportunities for the global biomaterial market. Factors such as stringent regulatory requirements and limitations of biomaterials are inhibiting the growth of the global market.
The U.S. had been the largest country for biomaterial market and is expected to continue being the largest market during the forecast period. The polymer biomaterial market is anticipated to witness highest growth during the forecast period, owing to their light weight, higher flexibility, biochemical resistance property, availability in various compositions and ease of manufacturing products with desired specifications.
Some of the key companies operating in the global biomaterial market include Corbion N.V., Wright Medical Technology Inc., Zimmer Biomet Holdings Inc., Royal DSM, Berkeley Advanced Biomaterials Inc., Cam Bioceramics BV and Collagen Matrix Inc.
